Please wait while we load the requested 10-Q report or click the link below:
Three Months Ended March 31,
(in millions, except per share amounts)
Product revenues, net
GAAP Operating income
Non-GAAP Operating income
GAAP Net income
Non-GAAP Net income
GAAP Net income per share - diluted
Non-GAAP Net income per share - diluted
The following information was filed by Vertex Pharmaceuticals Inc Ma (VRTX) on Wednesday, April 29, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Vertex Pharmaceuticals Inc Ma's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Vertex Pharmaceuticals Inc Ma.